- Trials with a EudraCT protocol (17)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
17 result(s) found for: Clinical attachment loss.
Displaying page 1 of 1.
EudraCT Number: 2019-003541-15 | Sponsor Protocol Number: 2019-Fungi | Start Date*: 2020-02-19 | |||||||||||
Sponsor Name:Aarhus University | |||||||||||||
Full Title: Adjunct effect of fluconazole in the treatment of Candida-associated refractory severe periodontitis – A single-center, placebo-controlled, triple blind, randomized clinical trial | |||||||||||||
Medical condition: Periodontitis. The participants are in good general health, but have at least 2 residual dental lesions after periodontal treatment (standard care). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004493-34 | Sponsor Protocol Number: 2017/06NOV/503 | Start Date*: 2018-01-02 |
Sponsor Name:Cliniques universitaires Saint-Luc | ||
Full Title: Evaluation of multiple subgingival irrigations with 10% povidone iodine after scaling and root planing : a randomized clinical trial | ||
Medical condition: Periodontitis is characterized by alveolar bone loss induced by the host immune response to bacterial insult. Because povidone iodine is known to be a powerful antiseptic, there is biologic rationa... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000741-39 | Sponsor Protocol Number: 6996 | Start Date*: 2019-11-07 |
Sponsor Name:Hôpitaux Universitaires de Strasbourg | ||
Full Title: EFFECT OF AZITHROMYCIN ON THE PROPORTION OF FAILURES OF SEVERE PERIODONTITIS NON-SURGICAL TREATMENTS : A RANDOMIZED, DOUBLE-BLIND VERSUS PLACEBO STUDY | ||
Medical condition: Periodontology | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2006-001367-36 | Sponsor Protocol Number: DoxP-01/2006 | Start Date*: 2006-12-05 | |||||||||||
Sponsor Name:Prof. Dr. Peter Eickholz | |||||||||||||
Full Title: Benefit of adjunctive systemic postsurgical doxycycline in regenerative periodontal surgery | |||||||||||||
Medical condition: Periodontitis is an opportunistic infectious disease that destroys the periodontal attachment and bone. Bacterial plaque (biofilm) on the teeth adjacent to the gingiva is the necessary cause gingiv... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005660-27 | Sponsor Protocol Number: OP-P-5265-1 | Start Date*: 2008-02-13 | |||||||||||
Sponsor Name:OraPharma Inc. | |||||||||||||
Full Title: Multi-Center Phase 3 Trial of Minocycline HCl 1mg Microspheres for the Use in Subjects with Peri-Implantitis | |||||||||||||
Medical condition: peri-implantitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020404-29 | Sponsor Protocol Number: H9V-MC-GFRF | Start Date*: 2011-04-08 | |||||||||||
Sponsor Name:Eli Lilly and Company Limited, Indianapolis | |||||||||||||
Full Title: A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients with Diabetic Kidney Disease due to Type 1 or Type 2 D... | |||||||||||||
Medical condition: Patients with Diabetic Kidney Disease due to Type 1 or Type 2 Diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) CZ (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004724-11 | Sponsor Protocol Number: 294568 | Start Date*: 2014-09-22 |
Sponsor Name:Karolinska Institute | ||
Full Title: Surgical treatment of peri-implantitis with and without systemically adjunctive antibiotics A prospective, open, randomized, three armed, parallel, placebo controlled clinical trial | ||
Medical condition: peri-implantitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-010830-23 | Sponsor Protocol Number: H8O-EW-GWDL | Start Date*: 2009-08-21 | |||||||||||
Sponsor Name:Eli Lilly and Company Limited | |||||||||||||
Full Title: Efficacy of Once-Weekly Exenatide versus Once or Twice Daily Insulin Detemir in Patients with Type 2 Diabetes Treated with Metformin Alone or in Combination with Sulphonylurea | |||||||||||||
Medical condition: Diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) IE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003392-39 | Sponsor Protocol Number: M/31416/51 | Start Date*: 2008-02-06 |
Sponsor Name:Laboratorios Almirall SA | ||
Full Title: Standardized sTudy with Almotriptan in eaRly Treatment of migraine, START. An international, open-label, single arm, effectiveness and safety study of Almotriptan in primary care seeting. | ||
Medical condition: Migraine | ||
Disease: | ||
Population Age: | Gender: Male, Female | |
Trial protocol: FR (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-000634-21 | Sponsor Protocol Number: 64304500CRD2001 | Start Date*: 2016-11-08 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of JNJ-64304500 in Subjects with Moderately to Severely Active Cro... | |||||||||||||
Medical condition: Active Crohn's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (GB - no longer in EU/EEA) HU (Completed) PL (Completed) FR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015953-18 | Sponsor Protocol Number: DORIPED3002 | Start Date*: 2010-05-28 | |||||||||||
Sponsor Name:Janssen-Cilag International NV, Turnhoutseweg 30, 2340 Beerse, Belgium | |||||||||||||
Full Title: A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infec... | |||||||||||||
Medical condition: Complicated Urinary Tract Infections | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Prematurely Ended) CZ (Completed) PL (Temporarily Halted) LV (Prematurely Ended) DE (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-020380-20 | Sponsor Protocol Number: R331333-PAI2005/KF5503-59 | Start Date*: 2012-03-09 | |||||||||||
Sponsor Name:Janssen Research & Development, L.L.C. | |||||||||||||
Full Title: Open-Label Evaluation of the Pharmacokinetic Profile and Safety of Tapentadol Oral Solution for the Treatment of Postsurgical Pain in Children and Adolescents Aged From 6 to Less Than 18 Years | |||||||||||||
Medical condition: Pain | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-000648-86 | Sponsor Protocol Number: OPN-FLU-CS-3206 | Start Date*: 2019-10-01 | |||||||||||
Sponsor Name:OptiNose US, Inc. | |||||||||||||
Full Title: A 24-Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 186 and 372 μg of OPN-375 Twice a Day (B... | |||||||||||||
Medical condition: Chronic rhinosinusitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) CZ (Completed) PL (Completed) ES (Ongoing) BG (Completed) RO (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-004330-24 | Sponsor Protocol Number: H3E-MC-S104 | Start Date*: 2009-02-20 | ||||||||||||||||
Sponsor Name:Eli Lilly and Company | ||||||||||||||||||
Full Title: A Phase 2 Study of Pemetrexed and Cisplatin plus Cetuximab followed by Pemetrexed and Cetuximab Maintenance Therapy in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (Stage... | ||||||||||||||||||
Medical condition: Locally Advanced or Metastatic Non-Small Cell Lung Cancer (Stage IIIB or IV) other than Predominantly Squamous Cell Histology | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) AT (Completed) NL (Completed) ES (Completed) IT (Completed) GR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-004837-54 | Sponsor Protocol Number: RABGRD3003 | Start Date*: 2009-03-05 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Multicenter, Double-Blind, Parallel-Group Study to Evaluate Short-Term Safety and Efficacy and Long-Term Maintenance of Two Dose Levels of Rabeprazole Sodium Delayed-Release Pediatric Bead Formul... | |||||||||||||
Medical condition: Endoscopically proven gastroesophageal reflux disease (GERD) in a paediatric population of 1 to 11 year old subjects. | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) BE (Completed) FR (Completed) NL (Ongoing) IT (Completed) BG (Not Authorised) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-010739-42 | Sponsor Protocol Number: H6D-MC-LVID | Start Date*: 2009-10-01 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Global Multicenter Study to Evaluate the Efficacy and Safety of Tadalafil Once Daily Dosing for 12 Weeks in Men with Signs ... | |||||||||||||
Medical condition: Benign Prostatic Hyperplasia (BPH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) NL (Completed) BE (Completed) AT (Completed) IT (Completed) FR (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-014803-30 | Sponsor Protocol Number: H9X-MC-GBDB | Start Date*: 2010-06-09 | |||||||||||
Sponsor Name:Lilly S.A. | |||||||||||||
Full Title: Estudio abierto, aleatorizado, con dos ramas paralelas, comparativo de no inferioridad de los efectos de dos dosis de LY2189265 versus insulina glargina sobre el control glucémico en pacientes con ... | |||||||||||||
Medical condition: Diabetes Mellitus tipo 2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) SE (Completed) FR (Completed) HU (Completed) SK (Completed) CZ (Completed) BE (Completed) GR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
